for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Utah Medical Products, Inc.

UTMD.OQ

Latest Trade

87.50USD

Change

-0.32(-0.36%)

Volume

1,976

Today's Range

87.40

 - 

88.58

52 Week Range

77.55

 - 

107.95

As of on the NASDAQ ∙ Minimum 15 minute delay

Latest Developments

UTMD Reports Audited Year 2020 And Fourth Quarter Financial Performance

Jan 28 (Reuters) - Utah Medical Products Inc <UTMD.O>::UTMD REPORTS AUDITED YEAR 2020 AND FOURTH QUARTER FINANCIAL PERFORMANCE.

Utah Medical Products Posts Quarterly Diluted EPS $0.803

Oct 27 (Reuters) - Utah Medical Products Inc <UTMD.O>::UTMD REPORTS FINANCIAL PERFORMANCE FOR THIRD QUARTER AND NINE MONTHS OF YEAR 2020.UTAH MEDICAL PRODUCTS INC - QTRLY NET SALES $ 10.5 MILLION VERSUS $ 12.5 MILLION.UTAH MEDICAL PRODUCTS INC - QTRLY DILUTED EPS $0.803.

UTMD Reports Quarterly EPS Of $0.359

July 28 (Reuters) - Utah Medical Products Inc <UTMD.O>::UTMD REPORTS FINANCIAL PERFORMANCE FOR SECOND CALENDAR QUARTER AND FIRST HALF 2020.UTAH MEDICAL PRODUCTS INC - QTRLY EARNINGS PER SHARE OF $0.359.

Utah Medical Products Increases Quarterly Dividend To $0.28 Per Share

Nov 5 (Reuters) - Utah Medical Products Inc <UTMD.O>::UTAH MEDICAL PRODUCTS- INCREASING QUARTERLY DIVIDEND TO $0.28 PER SHARE, UP 2% OVER PRIOR QUARTER.

UTMD Reports Q3 Earnings Per Share $0.991

Oct 24 (Reuters) - Utah Medical Products Inc <UTMD.O>::UTMD REPORTS FINANCIAL PERFORMANCE FOR THIRD QUARTER AND NINE MONTHS OF YEAR 2019.Q3 EARNINGS PER SHARE $0.991.QTRLY NET SALES $12.5 MILLION VERSUS $10.4 MILLION.

Utah Medical Products Qtrly Net Sales $11.9 Million, UP 8%

July 30 (Reuters) - Utah Medical Products Inc <UTMD.O>::UTAH MEDICAL PRODUCTS, INC. REPORTS FINANCIAL PERFORMANCE FOR SECOND QUARTER 2019.UTAH MEDICAL PRODUCTS INC QTRLY EARNINGS PER SHARE $.944.UTAH MEDICAL PRODUCTS INC QTRLY NET SALES $11.9 MILLION, UP 8%.

Utah Medical Products Reports Financial Performance For First Quarter 2019

April 25 (Reuters) - Utah Medical Products Inc <UTMD.O>::UTAH MEDICAL PRODUCTS, INC. REPORTS FINANCIAL PERFORMANCE FOR FIRST QUARTER 2019.UTAH MEDICAL PRODUCTS INC - QTRLY EARNINGS PER SHARE $0.840.UTAH MEDICAL PRODUCTS INC QTRLY EARNINGS PER SHARE $0.840.UTAH MEDICAL PRODUCTS INC QTRLY NET SALES $10.7 MILLION VERSUS $10.9 MILLION.

Utah Medical Products Inc QTRLY Earnings Per Share $0.905

Utah Medical Products Inc <UTMD.O>::UTMD REPORTS AUDITED YEAR 2018 AND FOURTH QUARTER FINANCIAL PERFORMANCE.UTAH MEDICAL PRODUCTS INC QTRLY EARNINGS PER SHARE $0.905.UTAH MEDICAL PRODUCTS INC QTRLY NET SALES $9.8 MILLION VERSUS $10.2 MILLION.UTAH MEDICAL PRODUCTS INC QTRLY EPS BEFORE GILTI TAX$0.940.UTAH MEDICAL PRODUCTS INC - "EXPECTS WORLDWIDE MACROECONOMIC CONDITIONS TO WEAKEN, WHICH MAY AFFECT DEMAND FOR DISCRETIONARY SPECIALTY MEDICAL DEVICES".UTAH MEDICAL PRODUCTS INC - "CONTINUING TRADE WAR WITH CHINA COULD HAVE SIGNIFICANT ADVERSE EFFECTS ON UTMD".UTAH MEDICAL PRODUCTS INC - "ON SUBJECT OF BREXIT, UTMD DOES NOT FORESEE A MATERIAL IMPACT ON ITS FINANCIAL RESULTS IN 2019".UTAH MEDICAL PRODUCTS INC - CURRENTLY PROJECTS UTMD 2019 USD CONSOLIDATED REVENUES MAY BE IN RANGE OF 9-10% HIGHER THAN IN 2018.UTAH MEDICAL PRODUCTS INC - "CURRENTLY PROJECTS UTMD 2019 USD CONSOLIDATED REVENUES MAY BE IN RANGE OF 9-10% HIGHER THAN IN 2018".

Utah Medical Products & CooperSurgical Entered Agreement

Jan 7 (Reuters) - Utah Medical Products Inc <UTMD.O>::UTAH MEDICAL PRODUCTS SAYS ON DEC 31, CO & COOPERSURGICAL INC ENTERED DEFINITIVE AGREEMENT - SEC FILING.UTAH MEDICAL PRODUCTS - BASIC TERMS OF DEAL INCLUDE A UTMD CASH PAYMENT OF $21 MILLION TO CSI, PURCHASE OF CSI'S RESALEABLE INVENTORY.UTAH MEDICAL PRODUCTS - AGREEMENT TO BUY REMAINING 4.75 YEAR LIFE OF EXCLUSIVE DISTRIBUTION AGREEMENT BETWEEN COOPERSURGICAL AND FEMCARE LTD.UTAH MEDICAL PRODUCTS INC - AFTER FEB. 1, 2019, CSI WILL NO LONGER ACCEPT ORDERS OR SHIP FILSHIE CLIP SYSTEM DEVICES TO CUSTOMERS.

Utah Medical Products Q3 Earnings Per Share $1.802

Oct 23 (Reuters) - Utah Medical Products Inc <UTMD.O>::UTAH MEDICAL PRODUCTS, INC. REPORTS FINANCIAL PERFORMANCE FOR THIRD QUARTER 2018.Q3 NON-GAAP EARNINGS PER SHARE $0.954.Q3 GAAP EARNINGS PER SHARE $1.802.QUARTERLY NET SALES $10.4 MILLION VERSUS $10.1 MILLION.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up